The popular weight-loss drug Wegovy is no longer just for injections! A brand-new pill version has just been approved by the FDA, bringing a new level of convenience for many.
For a while now, the once-weekly Wegovy injection has been a go-to for adults managing obesity and those who are overweight with related health issues. But here's where it gets exciting: a pill form is now widely available across the U.S. through pharmacies and telehealth services. This new oral option contains the same active ingredient, semaglutide, as the injectable version and even shares its active compound with Ozempic. Essentially, it works by mimicking a natural hormone in your body called glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating your appetite and keeping your blood sugar in check.
Both the pill and the injection are designed to help adults achieve and maintain weight loss when combined with a healthy diet and regular exercise. However, it's important to note that only the injectable form is currently approved for use in children aged 12 and older who have obesity. The pill version is still exclusively for adults.
So, how does this new pill stack up against the familiar injection? Let's dive in!
Do Semaglutide Pills Work as Well as Injections?
The primary difference lies in how the medication enters your system. With an injection, semaglutide is absorbed directly into your bloodstream. The pill, on the other hand, has to navigate your digestive system first. This means it passes through your stomach and intestines, where some of the active ingredient can be broken down by digestive enzymes before it's absorbed through your gut lining.
As Dr. Chika Anekwe, an obesity medicine specialist at Massachusetts General Hospital, explains, "only a small fraction [of the pill] reaches the bloodstream." This is a common characteristic when comparing oral medications to injected ones.
And this is the part most people miss: While the pill exposes your digestive tract to more semaglutide than an injection, its local effects on the gut are minimal. The significant benefits, according to Dr. Anekwe, "still require absorption and systemic signaling," meaning the key actions only begin once the drug makes its way into your bloodstream.
To compensate for this digestive journey, the pill version requires a much higher dose than the injection. The maximum dose for the pill is 25 milligrams, a significant jump from the 2.4 milligrams of the weekly injection.
But here's where it gets challenging for some: the pill comes with very specific instructions. It needs to be taken on an empty stomach in the morning with a small amount of water, and you must wait at least 30 minutes before eating, drinking, or taking other medications. This meticulous timing ensures the medication is absorbed effectively at the intended dose. The injectable version offers more flexibility, with no specific timing or fasting requirements.
During a recent Endocrine Society webinar, Dr. Priya Jaisinghani, an endocrinologist and obesity medicine specialist at NYU Langone Health, discussed the effectiveness of both formulations. While there hasn't been a direct, long-term comparison study between the daily pill and the weekly injection, clinical trials for each drug taken separately suggest they offer remarkably similar weight loss results when used as directed.
For instance, the STEP-1 trial for the 2.4-mg injectable showed participants lost an average of about 14.4% of their body weight. In the OASIS 4 trial for the 25-mg pill, participants achieved an average weight loss of about 13.9%. These findings indicate that both the pill and the injection are comparable in their efficacy for weight management.
Is the Wegovy Pill as Safe as the Injection?
Yes, the clinical trials suggest that the safety profiles of the Wegovy pill and injection are very similar, with the most common side effects being gastrointestinal issues such as nausea, diarrhea, vomiting, and constipation. Approximately three-quarters of users experience these mild to moderate symptoms. However, for both forms of the drug, a small percentage of patients (around 7% to 10%) discontinue the medication due to these effects.
(It's worth noting that some real-world data hint at a higher rate of discontinuation within the first year for GLP-1 medications in general. This could be due to a combination of factors, including side effects and the cost of the medication.)
Who Might Benefit More from the Pill or the Injection?
Several factors can influence whether someone opts for the pill or the injection. For individuals who have a strong aversion to needles, the pill version is a clear advantage. It also offers a significant benefit for those who may not have consistent access to refrigeration, such as frequent travelers, as the pills can be stored at room temperature. The injectables, on the other hand, typically require refrigeration between 36 and 46 degrees Fahrenheit (2 to 8 degrees Celsius), though they can be stored at room temperature for a limited time if unopened.
However, the strict daily regimen for the pill – taking it on an empty stomach with specific food and drink restrictions afterward – might be a hurdle for some. For these individuals, the simplicity of a once-weekly injection might be more appealing.
Cost and insurance coverage can also play a deciding role. The pill might be a more accessible option for those without insurance, as it potentially has a lower out-of-pocket expense.
And besides lifestyle and financial considerations, there's a crucial difference in who can use each version: While the injectable Wegovy is approved for adolescents aged 12 and older with obesity, the Wegovy pill is currently cleared for adults only.
What are your thoughts on the new oral option for Wegovy? Do you think the convenience of a pill outweighs the stricter dosing schedule, or would you still prefer the injection? Share your opinions in the comments below!
